Preparation and in vitro release characteristics of curcumin in nanosuspensions

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 2, 2011, Pages 132-135

  Zhang, Hua ^a   Zhang, Liangke ^a   Yuan, Pei ^a   Wang, Chengyuan ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

Author keywords

Albumin; Curcumin; Nanosuspensions

Indexed keywords

ALBUMIN; CURCUMIN; NANOPARTICLE; SOLVENT; HERBACEOUS AGENT;

ARTICLE; BIOACCUMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EVAPORATION; FREEZE DRYING; IN VITRO STUDY; MEMBRANE RECONSTITUTION; MORPHOLOGY; NANOENCAPSULATION; NANOSUSPENSION; PARTICLE SIZE; SUSPENSION; TRANSPORT KINETICS; CHEMISTRY; CURCUMA LONGA; DRUG FORMULATION; EVALUATION; KINETICS; METHODOLOGY;

CURCUMA; CURCUMIN; DRUG COMPOUNDING; DRUGS, CHINESE HERBAL; KINETICS; NANOPARTICLES; PARTICLE SIZE;

EID: 79955952400     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20110209     Document Type: Article

References (8)

1. Maheshwari R K, Singh A K, Gaddipati J, et al. Multiple biological activities of curcumin: A short review [J]. Life Sci, 2006, 78(18):2081.
2. Sharma R, GescherA J, McLelland H R, et al. Pharmacoldynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer[J]. Clin Cancer Res, 2001, 7(7):1894.
3. Qiang Fu, Jin Sun, Wenping Zhang, et al. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery[J]. Recent Patents on Anti-Cancer Drug Discovery, 2009, 4:262.